SCHEMBL7835344

SCHEMBL7835344

Cn1[c]cc2cc(O)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CLK1 P49759 1/20 0.37
DYRK1A Q13627 1/20 0.37
DYRK1B Q9Y463 1/20 0.37
CYP1A2 P05177 1/20 0.35
BCHE P06276 2/20 0.34
ACHE P22303 2/20 0.34
ESR1 P03372 5/20 0.33
ESR2 Q92731 5/20 0.33
ALOX5 P09917 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29116707 0.84 HTR2A (0.38) KDM4EMEN1ALDH1A1GAAKMT2A
SCHEMBL2056889 0.76 KDM4E (0.42) KDM4EMEN1ALDH1A1KMT2ACYP1A2
SCHEMBL7832820 0.71 SMN1; SMN2 (0.53) KDM4EMEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL137023 0.70 CA12 (0.39) KDM4EMEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL1400341 0.67 PRKCI (0.59) KDM4EMEN1ALDH1A1GAAKMT2A
SCHEMBL29874172 0.67 PRKCI (0.59) KDM4EMEN1ALDH1A1GAAKMT2A
SCHEMBL11290755 0.67 CLK1 (0.50) KDM4EMEN1ALDH1A1GAAKMT2A
SCHEMBL1091680 0.65 CYP2A6 (0.42) KDM4EMEN1ALDH1A1GAAKMT2A
SCHEMBL4378545 0.65 MEN1 (0.57) KDM4EMEN1ALDH1A1GAAKMT2A
SCHEMBL30574359 0.64 USP7 (0.48) ALDH1A1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed